CS229287A2 - Method of 1,4-dihydropyridine-3,5-dicarboxyl acid's asymmetric heterocyclic ester's derivative preparation - Google Patents

Method of 1,4-dihydropyridine-3,5-dicarboxyl acid's asymmetric heterocyclic ester's derivative preparation

Info

Publication number
CS229287A2
CS229287A2 CS872292A CS229287A CS229287A2 CS 229287 A2 CS229287 A2 CS 229287A2 CS 872292 A CS872292 A CS 872292A CS 229287 A CS229287 A CS 229287A CS 229287 A2 CS229287 A2 CS 229287A2
Authority
CS
Czechoslovakia
Prior art keywords
group
dihydropyridine
dicarboxyl acid
derivative preparation
heterocyclic ester
Prior art date
Application number
CS872292A
Other languages
English (en)
Other versions
CS268828B2 (en
Inventor
Jacques Ing Robin
Didier Ing Pruneau
Francois Ing Bellamy
Original Assignee
Fournier Innovation Et Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fournier Innovation Et Soc filed Critical Fournier Innovation Et Soc
Publication of CS229287A2 publication Critical patent/CS229287A2/cs
Publication of CS268828B2 publication Critical patent/CS268828B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Coloring (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Laminated Bodies (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS872292A 1986-04-02 1987-04-01 Method of 1,4-dihydropyridine-3,5-dicarboxyl acid's asymmetric heterocyclic ester's derivative preparation CS268828B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8604685A FR2596760B1 (fr) 1986-04-02 1986-04-02 Derives dissymetriques de l'acide 1,4-dihydropyridine-3,5-dicarboxylique, procedes de preparation et utilisation en therapeutique

Publications (2)

Publication Number Publication Date
CS229287A2 true CS229287A2 (en) 1989-08-14
CS268828B2 CS268828B2 (en) 1990-04-11

Family

ID=9333794

Family Applications (1)

Application Number Title Priority Date Filing Date
CS872292A CS268828B2 (en) 1986-04-02 1987-04-01 Method of 1,4-dihydropyridine-3,5-dicarboxyl acid's asymmetric heterocyclic ester's derivative preparation

Country Status (25)

Country Link
US (2) US4806544A (cs)
EP (1) EP0240398B1 (cs)
JP (1) JPS6317883A (cs)
KR (1) KR900005956B1 (cs)
CN (1) CN1015460B (cs)
AT (1) ATE63555T1 (cs)
AU (2) AU590690B2 (cs)
CS (1) CS268828B2 (cs)
DD (2) DD263291A5 (cs)
DE (1) DE3770037D1 (cs)
DK (1) DK161787A (cs)
ES (1) ES2028886T3 (cs)
FI (1) FI86302C (cs)
FR (1) FR2596760B1 (cs)
GR (1) GR3002267T3 (cs)
HU (2) HUT53080A (cs)
IL (1) IL81933A (cs)
NO (1) NO167029C (cs)
NZ (1) NZ219758A (cs)
OA (1) OA08508A (cs)
PT (1) PT84560B (cs)
SU (1) SU1586515A3 (cs)
TN (1) TNSN87043A1 (cs)
YU (2) YU57287A (cs)
ZA (1) ZA872258B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4092406A1 (cs) * 1989-12-22 1993-04-01
DE4125271A1 (de) * 1991-07-31 1993-02-11 Bayer Ag Neue n-alkylierte 1,4-dihydropyridindicarbonsaeureester
WO1993006082A1 (en) * 1991-09-13 1993-04-01 Merck & Co., Inc. Process for the preparation of 4-substituted-1,4-dihydropyridines
EP2410854B1 (en) * 2009-03-27 2016-06-29 Council of Scientific & Industrial Research Substituted 1, 4-dioxa-8-azaspiro ý4,5¨decanes useful as fungicides and a process for the preparation thereof
WO2012123966A1 (en) 2011-03-04 2012-09-20 Arch Pharmalabs Limited Process for the preparation of 4 -substituted -1, 4-dihydropyridines
CN102796111B (zh) * 2012-09-10 2014-09-24 贵州大学 氧氮杂螺环酰胺基团的羧(磺)酸酯类化合物及制备方法和用途
CN104860873A (zh) * 2015-05-28 2015-08-26 石家庄学院 一种(s)-1,4-二氢吡啶钙离子拮抗剂的制备方法
CN108430989B (zh) * 2015-10-13 2021-10-08 轩竹生物科技有限公司 1,4-二氢吡啶-3,5-二羧酸酯衍生物的制备方法及中间体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670824C3 (de) * 1967-03-20 1978-08-03 Bayer Ag, 5090 Leverkusen 1,4-Dihydropyridin-33-dicarbonsäurealkylester
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
JPS4932542B1 (cs) * 1970-08-17 1974-08-31
GB1591089A (en) * 1976-12-17 1981-06-10 Fujisawa Pharmaceutical Co 1,4-dihydropyridine derivatives and process for preparation thereof
US4250312A (en) * 1979-12-28 1981-02-10 Argus Chemical Corp. Process for preparing 4-piperidone spiroketal compounds
US4250313A (en) * 1980-02-01 1981-02-10 Argus Chemical Corp. Process for preparing 4-piperidone spiroketal compounds
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
WO1983003249A1 (fr) * 1982-03-17 1983-09-29 Yoshitomi Pharmaceutical Derives de 1,4-dihydropyridine-3,5-dicarboxylate
JPS58159462A (ja) * 1982-03-17 1983-09-21 Yoshitomi Pharmaceut Ind Ltd 1,4−ジヒドロピリジン−3,5−ジカルボン酸エステル誘導体
FR2577552B1 (fr) * 1985-02-20 1987-09-04 Sori Soc Rech Ind Esters heterocycliques dissymetriques d'acides 1,4-dihydropyridine-3,5-dicarboxyliques, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
EP0240398A1 (fr) 1987-10-07
DD263291A5 (de) 1988-12-28
YU44714B (en) 1990-12-31
AU610753B2 (en) 1991-05-23
FI86302B (fi) 1992-04-30
HUT49613A (en) 1989-10-30
DE3770037D1 (de) 1991-06-20
NZ219758A (en) 1989-04-26
YU57287A (en) 1988-10-31
NO167029C (no) 1991-09-25
YU48088A (en) 1988-12-31
PT84560B (pt) 1989-11-30
KR870010055A (ko) 1987-11-30
AU590690B2 (en) 1989-11-09
IL81933A0 (en) 1987-10-20
NO167029B (no) 1991-06-17
PT84560A (fr) 1987-04-01
DK161787A (da) 1987-10-03
IL81933A (en) 1991-06-30
SU1586515A3 (ru) 1990-08-15
ATE63555T1 (de) 1991-06-15
ES2028886T3 (es) 1992-07-16
HUT53080A (en) 1990-09-28
FR2596760B1 (fr) 1988-12-09
DK161787D0 (da) 1987-03-30
GR3002267T3 (en) 1992-12-30
KR900005956B1 (ko) 1990-08-18
FR2596760A1 (fr) 1987-10-09
US4900833A (en) 1990-02-13
CS268828B2 (en) 1990-04-11
FI871316A7 (fi) 1987-10-03
ZA872258B (en) 1987-11-25
NO871339D0 (no) 1987-03-31
EP0240398B1 (fr) 1991-05-15
TNSN87043A1 (fr) 1990-01-01
FI86302C (fi) 1992-08-10
US4806544A (en) 1989-02-21
HU199479B (en) 1990-02-28
AU7041087A (en) 1987-10-08
JPS6317883A (ja) 1988-01-25
OA08508A (fr) 1988-07-29
FI871316A0 (fi) 1987-03-25
AU4126389A (en) 1989-12-21
CN1015460B (zh) 1992-02-12
DD278793A5 (de) 1990-05-16
NO871339L (no) 1987-10-05
CN87102452A (zh) 1987-10-14

Similar Documents

Publication Publication Date Title
DE69100079D1 (de) Naphthalin-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
FI874451A0 (fi) Menetelmä lääkeaineina käyttökelpoisten dihydropyridiinin johdannaisten valmistamiseksi
CA2089767A1 (en) Pyridinyl thiadiazolyl- and oxadiazolyl derivatives
FR2662701B1 (fr) Composition tinctoriale a base de 5,6-dihydroxyindolines et procede de teinture des fibres keratiniques.
DE69429708D1 (de) Galanthamin Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
CS229287A2 (en) Method of 1,4-dihydropyridine-3,5-dicarboxyl acid's asymmetric heterocyclic ester's derivative preparation
AT389108B (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE32221T1 (de) 3 n-substituierte 3,4-dihydropyrimidinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
ATE148697T1 (de) Neue benzopyranone, verfahren zu ihrer herstellung und verwendung
EP0169009A3 (en) Novel dihydropyridine derivatives and their production, formulation and use as pharmaceuticals
DE3866292D1 (de) Piperazinylalkylpiperazindion-derivate, ihre verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE3752001D1 (de) Enantiomerenreine 4,5-disubstituierte gamma-Butyrolactame, Verfahren zu ihrer Herstellung und ihre Verwendung
PT84084B (en) Process for preparing methionine-substituted 1,4-dihydropyridines
DE69301639D1 (de) Tetrahydronaphtalenderivate, ihre Herstellung und ihre therapeutische Verwendung
AT389309B (de) Malonsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung, enthaltend diese verbindungen